REFERENCES
- Cenci S, Toraldo G, Weitzmann M N, Roggia C, Gao Y, Qian W P, Sierra O, Pacifici R. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through INF-γ -induced class II transactivator. Proc Natl Acad SciUSA 2003; 100: 10405–10410
- Khosla S, Melton L J, Riggs B L. Estrogen and the male skeleton. J Clin Endocrinol Metab 2002; 87: 1443–1450
- Riggs B L, Khosla S, Melton J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002; 23: 279–302
- Roggia C, Gao Y, Cenci S, Weitzmann M N, Toraldo G, Isia G, Pacifici R. Up-regulation of TNF-∀ producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad SciUSA 2001; 98: 13960–13965
- Srivastava S, Toraldo G, Weitzmann M N, Cenci S, Ross P, Pacifici R. Estrogen decreases oesteoclast formation by down-regulating receptor activator of NF-kB ligand (RANKL)-induced JNK activation. J Biol Chem 2001; 276: 8836–8840
- Imamov O, Shim G J, Warner M, Gustafsson J A. Estrogen receptor β in health and disease. Biol Reprod 2005; 73: 866–871
- Lakoski S G, Herrington D M. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: A review article. Climacteric 2005; 8: 317–326
- Mendelsohn M E, Karas R H. Molecular and cellular basis of cardiovascular gender differences. Science 2005; 10: 1583–1587
- Miller A P, Chen Y F, Xing D Q, Feng W G, Oparil S. Hormone replacement therapy and inflammation: Interactions in cardiovascular disease. Hypertension 2003; 42: 657–663
- Mor G, Sapi E, Abrahams V M, et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 2003; 170: 114–122
- Shim G J, Gherman D, Kim H J, et al. Differential expression of oestrogen receptors in human secondary lymphoid tissues. J Pathol 2006; 208: 408–418
- Takao T, Kumagai C, Hisakawa N, Matsumoto R, Hashimoto K. Effect of 17 beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes. Endocrinology 2005; 184: 191–197
- Grimaldi C M, Cleary J, Dagtas A S, Moussai D, Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002; 109: 1625–1633
- Nancy P, Berrih-Aknin S. Differential estrogen receptor expression in autoimmune myasthenia gravis. Endocrinology 2005; 146: 2345–2353
- Revankar C M, Cimino D F, Sklar L A, Arterburn J B, Prossnitz E R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307: 1625–1630
- Stirone C, Duckles S P, Krause D N. Multiple forms of estrogen receptor-alpha in cerebral blood vessels: Regulation by estrogen. AmJ Physiol Endocrinol Metab 2003; 284: E184–192
- Zafar N, O'Malley B W. Urban renewal in the nucleus: Is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription?. Mol Endocrinol 2004; 18: 493–9
- Leung Y K, Mak P, Hassan S, Ho S M. Estrogen receptor (ER)-beta isoforms: A key to understanding ER-beta signaling. Proc Natl Acad SciUSA 2006; 29: 13162–13167
- Moore J T, McKee D D, Slentz-Kesler K, Moore L B, Jones S A, Horne E L, et al. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 1998; 47: 75–78
- Shim G J, Wang L, Andersson S, Nagy N, Kis L L, Zhang Q, Makela S, Warner M, Gustafsson J A. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad SciUSA 2003; 100: 6694–6699